Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Mar 1, 2016
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2016-02-29+130,000→ 130,000 totalExercise: $2.30Exp: 2026-03-01→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 29, 2016. This option vests in four equal installments over a four-year period from the date of grant.